WATSON PHARMACEUTICALS INC (WPI) has 56 open-market insider trades by 19 insiders since 2008. The most active filer is R. Todd Joyce, CFO-Global & PAO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Albert F. Hummel | Dir | — | 5 | $4.7M | 2012-05-29 |
| Michel J. Feldman | Dir | — | 4 | $3.9M | 2012-08-30 |
| Fred G. Weiss | Dir | — | 2 | $3.9M | 2012-07-30 |
| David A. Buchen | CLO | — | 4 | $3.9M | 2012-10-31 |
| Jack Michelson | Dir | — | 3 | $3.7M | 2012-06-07 |
| R. Todd Joyce | CFO-Global & PAO | — | 7 | $3.6M | 2012-10-31 |
| Andrew L. Turner | Dir | — | 7 | $3.3M | 2012-05-29 |
| Thomas R. Russillo | EVPGlobal Generics | — | 1 | $3.0M | 2010-12-31 |
| Charles D. Ebert | Sr. VPResearch & Development | — | 6 | $3.0M | 2012-03-14 |
| Ronald R. Taylor | Dir | — | 1 | $2.2M | 2012-05-30 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Michel J. Feldman | Director | Sell | $448K | 2012-08-30 |
| David A. Buchen | CLO | Sell | $2.0M | 2012-08-24 |
| R. Todd Joyce | CFO-Global & PAO | Sell | $772K | 2012-08-01 |
| Cathy Klema | Director | Sell | $1.3M | 2012-07-31 |
| Fred G. Weiss | Director | Sell | $2.4M | 2012-07-30 |
| Michael J. Fedida | Director | Sell | $350K | 2012-06-08 |
Companies that share insiders with WPI, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Jack Michelson | Director | Sell | $1.4M | 2012-06-07 |
| Ronald R. Taylor | Director | Sell | $2.2M | 2012-05-30 |
| Francois A. Menard | SVP & Global Generics R&D | Sell | $256K | 2012-05-29 |
| Andrew L. Turner | Director | Sell | $1.5M | 2012-05-29 |
| Albert F. Hummel | Director | Sell | $1.4M | 2012-05-29 |
| Albert Paonessa III | President & Inc. | Sell | $291K | 2012-05-08 |
| Michel J. Feldman | Director | Sell | $1.5M | 2012-05-07 |
| Albert F. Hummel | Director | Sell | $798K | 2012-05-02 |
| Charles D. Ebert | Sr. VP & Research & Development | Sell | $293K | 2012-02-29 |